Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INCYTE CORPINCY · Entity 3182 | EVP & General Counsel | July 14, 2023 | July 18, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INCYTE CORP
Report date July 14, 2023 · Filed July 18, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,724 |
Reported balance
After 2023-07-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-07-14 · Grant · Acquired 9,668 · Balance 69,724 F1: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Maria Pasquale's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2: Including the July 14, 2023 RSU Grant, this includes an aggregate of 42,226 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.76 · Expires 2033-07-13 | Direct | 20,275 |
Reported balance
After 2023-07-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-07-14 · Grant · Acquired 20,275 · Balance 20,275 F3: The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Maria Pasquale's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2: Including the July 14, 2023 RSU Grant, this includes an aggregate of 42,226 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
F3: The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2023 Filed Jul 18, 2023 20:00 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 20,275 | $0.00 Strike: $61.76 | $0.00 |
DisclosureSEC source: 0001209191-23-042548 · doc4.xml · derivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,275 Underlying: Common Stock · 20,275 shares Expires 2033-07-13 F3 · derivative.exercise_date: The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:00 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 9,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-042548 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,724 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Maria Pasquale's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Including the July 14, 2023 RSU Grant, this includes an aggregate of 42,226 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:00 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 8,468 | $62.08 | $525,693.44 |
DisclosureSEC source: 0001209191-23-041507 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,056 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. F2 · balance_after: This includes an aggregate of 32,558 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 802 | $0.00 Strike: $74.78 | $0.00 |
DisclosureSEC source: 0001209191-23-006174 · doc4.xml · derivative · entry 3 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 802 shares Expires 2032-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning January 2, 2022, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 802 | $84.06 | $67,416.12 |
DisclosureSEC source: 0001209191-23-006174 · doc4.xml · nonDerivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,524 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: Includes an aggregate of 49,571 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 802 | $74.78 | $59,973.56 |
DisclosureSEC source: 0001209191-23-006174 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,842 | $0.00 Strike: $74.78 | $0.00 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · derivative · entry 18 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,842 shares Expires 2032-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Beginning January 2, 2022, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,644 | $0.00 Strike: $83.58 | $0.00 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · derivative · entry 17 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,644 shares Expires 2031-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,374 | $0.00 Strike: $80.50 | $0.00 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · derivative · entry 16 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,374 shares Expires 2030-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Beginning January 17, 2020, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2020 and the remainder vesting monthly over three years. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,861 | $0.00 Strike: $72.27 | $0.00 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · derivative · entry 15 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,861 shares Expires 2029-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,438 | $0.00 Strike: $68.62 | $0.00 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · derivative · entry 14 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,438 shares Expires 2028-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,865 | $0.00 Strike: $65.36 | $0.00 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · derivative · entry 13 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,865 shares Expires 2028-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting on April 9, 2019 and the remainder vesting monthly over three years. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 4,842 | $84.73 | $410,262.66 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 12 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,524 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. F2 · balance_after: Includes an aggregate of 49,571 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 4,842 | $74.78 | $362,084.76 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 11 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 5,644 | $85.07 | $480,135.08 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 10 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,524 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 5,644 | $83.58 | $471,725.52 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 9 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 14,374 | $84.73 | $1,217,909.02 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 8 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,524 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 14,374 | $80.50 | $1,157,107.00 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 7 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 11,861 | $84.70 | $1,004,626.70 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 6 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,524 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 11,861 | $72.27 | $857,194.47 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 5 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 10,438 | $84.70 | $884,098.60 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 4 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,524 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 10,438 | $68.62 | $716,255.56 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 3 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 12,865 | $84.69 | $1,089,536.85 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,524 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 12,865 | $65.36 | $840,856.40 |
DisclosureSEC source: 0001209191-23-005896 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 19,354 | $0.00 Strike: $83.20 | $0.00 |
DisclosureSEC source: 0001209191-23-004565 · doc4.xml · derivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,354 Underlying: Common Stock · 19,354 shares Expires 2033-01-19 F3 · derivative.exercise_date: Beginning January 20, 2023, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2023 and the remainder vesting monthly over three years. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:00 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 4,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004565 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,524 F1 · shares: Represents shares of common stock underlying performance shares earned upon the achievement of performance criteria determined to be satisfied on January 20, 2023. The earned shares will vest on the third anniversary of the July 2, 2020 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in January 2020 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 175% of the number of performance shares awarded. F2 · balance_after: This includes an aggregate of 49,571 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. The aggregate amount also includes the additional Performance Stock Units earned on January 20, 2023. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 20:09 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 3,043 | $79.25 | $241,157.75 |
DisclosureSEC source: 0001209191-22-041077 · doc4.xml · nonDerivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,544 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. F3 · balance_after: Including the July 2, 2022 RSU Grant, this includes an aggregate of 31,062 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. Read SEC document |
| July 02, 2022 Filed Jul 6, 2022 20:09 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 18,332 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001209191-22-041077 · doc4.xml · derivative · entry 3 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,332 Underlying: Common Stock · 18,332 shares Expires 2032-07-01 F4 · derivative.exercise_date: Beginning July 2, 2022, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 02, 2022 Filed Jul 6, 2022 20:09 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 13,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-041077 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,587 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Maria Pasquale's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
| April 09, 2022 Filed Apr 12, 2022 20:12 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 517 | $80.95 | $41,851.15 |
DisclosureSEC source: 0001209191-22-024137 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,058 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. F2 · balance_after: Includes an aggregate of 46,929 shares of common stock issuable pursuant to previously reported earned performance stock units and restricted stock units that have not vested. Read SEC document |
| January 19, 2022 Filed Jan 21, 2022 21:20 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 15,054 | $0.00 Strike: $74.78 | $0.00 |
DisclosureSEC source: 0001209191-22-004421 · doc4.xml · derivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,054 Underlying: Common Stock · 15,054 shares Expires 2032-01-18 F1 · derivative.exercise_date: Beginning January 19, 2022, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2022 and the remainder vesting monthly over three years. Read SEC document |
| January 01, 2022 Filed Jan 5, 2022 21:17 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 14,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001656 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,575 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 100% on December 31, 2025, subject to Maria Pasquale's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Includes an aggregate of 40,930 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:18 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 2,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-066415 · doc4.xml · nonDerivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,112 F2 · shares: Represents shares of common stock underlying performance shares earned upon the interim achievement of performance criteria determined to be satisfied on November 19, 2021. The earned shares will vest on the third anniversary of the July 2, 2021 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in February 2021 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 150% of the number of performance shares awarded. F3 · balance_after: Including the Performance Stock Units earned on November 19, 2021, this includes an aggregate of 26,467 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:18 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 379 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-066415 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,757 F1 · shares: Represents shares of common stock underlying performance shares earned upon the interim achievement of performance criteria determined to be satisfied on November 19, 2021. The earned shares will vest on the third anniversary of the July 2, 2020 grant date, subject to the Reporting Persons continued service with the Issuer. Each performance share represents the right to receive one or more shares of common stock based on, and subject to, the achievement of specified financial and development performance criteria determined by the Issuers Compensation Committee in January 2020 as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person is entitled to receive over the three year performance period ranges from 0% to 175% of the number of performance shares awarded. Read SEC document |
| September 24, 2021 Filed Sep 28, 2021 12:18 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 382 | $0.00 Strike: $65.36 | $0.00 |
DisclosureSEC source: 0001209191-21-057866 · doc4.xml · derivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,912 Underlying: Common Stock · 382 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| September 24, 2021 Filed Sep 28, 2021 12:18 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 382 | $65.36 | $24,967.52 |
DisclosureSEC source: 0001209191-21-057866 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This includes an aggregate of 23,733 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:34 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 15,054 | $0.00 Strike: $83.58 | $0.00 |
DisclosureSEC source: 0001209191-21-045819 · doc4.xml · derivative · entry 3 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,054 Underlying: Common Stock · 15,054 shares Expires 2031-07-01 F4 · derivative.exercise_date: Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:34 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 2,241 | $83.58 | $187,302.78 |
DisclosureSEC source: 0001209191-21-045819 · doc4.xml · nonDerivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,805 F2 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock. F3 · balance_after: Including the July 2, 2021 Restricted Stock Unit Grant, this includes an aggregate of 23,733 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:34 UTC | INCYTE CORP INCY · Entity 3182 | GrantCommon Stock | 7,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-045819 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,046 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Maria Pasquale's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 255 | $0.00 Strike: $65.36 | $0.00 |
DisclosureSEC source: 0001209191-21-042374 · doc4.xml · derivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,294 Underlying: Common Stock · 255 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| June 18, 2021 Filed Jun 22, 2021 20:04 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 255 | $65.36 | $16,666.80 |
DisclosureSEC source: 0001209191-21-042374 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This includes an aggregate of 22,302 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 20:57 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 127 | $0.00 Strike: $65.36 | $0.00 |
DisclosureSEC source: 0001209191-21-028579 · doc4.xml · derivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,549 Underlying: Common Stock · 127 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 20:57 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 127 | $65.36 | $8,300.72 |
DisclosureSEC source: 0001209191-21-028579 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This includes an aggregate of 22,302 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 20:14 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 517 | $79.96 | $41,339.32 |
DisclosureSEC source: 0001209191-21-026432 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,811 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. F2 · balance_after: Includes an aggregate of 22,302 shares of common stock issuable pursuant to previously reported earned performance stock units and restricted stock units that have not vested. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:17 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 128 | $0.00 Strike: $65.36 | $0.00 |
DisclosureSEC source: 0001209191-21-020775 · doc4.xml · derivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,676 Underlying: Common Stock · 128 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:17 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 128 | $65.36 | $8,366.08 |
DisclosureSEC source: 0001209191-21-020775 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This includes an aggregate of 23,784 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:38 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 127 | $0.00 Strike: $65.36 | $0.00 |
DisclosureSEC source: 0001209191-21-011876 · doc4.xml · derivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,804 Underlying: Common Stock · 127 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:38 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionCommon Stock | 127 | $65.36 | $8,300.72 |
DisclosureSEC source: 0001209191-21-011876 · doc4.xml · nonDerivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This includes an aggregate of 23,784 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 21:35 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 12,743 | $0.00 Strike: $90.56 | $0.00 |
DisclosureSEC source: 0001209191-21-004315 · doc4.xml · derivative · entry 1 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,743 Underlying: Common Stock · 12,743 shares Expires 2031-01-14 F1 · derivative.exercise_date: Beginning January 15, 2021, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2021 and the remainder vesting monthly over three years. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 21:15 UTC | INCYTE CORP INCY · Entity 3182 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 127 | $0.00 Strike: $65.36 | $0.00 |
DisclosureSEC source: 0001209191-21-003414 · doc4.xml · derivative · entry 2 Pasquale Maria E · CIK 0001736295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,931 Underlying: Common Stock · 127 shares Expires 2028-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Beginning April 9, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.